Literature DB >> 3254878

Synthesis and radioiodination of tyramine cellobiose for labeling monoclonal antibodies.

S A Ali1, J F Eary, S D Warren, C C Badger, K A Krohn.   

Abstract

A tyramine cellobiose (TCB) adduct was synthesized by the reductive amination of cellobiose by tyramine with a product yield of 78%. The TCB adduct was purified by chromatography and then iodinated using the chloramine-T method. After iodination, the adduct was activated with cyanuric chloride and linked to protein by incubation at room temperature for 2 h. Immunoreactivity and avidity were well maintained compared to electrophilically radioiodinated 1A14 whole antibody. The tumor uptake and retention were strikingly greater with iodinated TCB-antibody compared to that of the conventionally iodinated antibody; whereas, the plasma clearance curve and uptake in other organs were not changed. This method of labeling increases the retention time of radioiodine in tumors and thus extends to iodinated antibodies one of the advantages of indium labels, namely that the isotope is not readily washed out of the tumor after it becomes localized.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3254878     DOI: 10.1016/s0969-8051(88)80015-5

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum B        ISSN: 0883-2897


  2 in total

1.  N-Succinimidyl guanidinomethyl iodobenzoate protein radiohalogenation agents: influence of isomeric substitution on radiolabeling and target cell residualization.

Authors:  Jaeyeon Choi; Ganesan Vaidyanathan; Eftychia Koumarianou; Darryl McDougald; Marek Pruszynski; Takuya Osada; Tony Lahoutte; H Kim Lyerly; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2014-08-01       Impact factor: 2.408

2.  L-Tyrosine Confers Residualizing Properties to a d-Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies.

Authors:  Fook T Lee; Ingrid J G Burvenich; Nancy Guo; Pece Kocovski; Henri Tochon-Danguy; Uwe Ackermann; Graeme J O'Keefe; Sylvia Gong; Angela Rigopoulos; Zhanqi Liu; Hui K Gan; Andrew M Scott
Journal:  Mol Imaging       Date:  2016-07-25       Impact factor: 4.488

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.